Atlas Trials

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Clinical trial NCT05357573 · COMPLETED

Trial details

NCT number
NCT05357573
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Tumor-Induced Osteomalacia (TIO)
Start date
2022-09-07
Primary completion
2023-11-22
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.